GE HealthCare Technologies revenue and financials

GEHC · NASDAQ · USD

$64.77Change from previous close: −1.48%Absolute change: −$0.97

Close · October 6, 2026

In the fiscal year ended December 2025, GE HealthCare Technologies reported revenue of $20.63B (+4.84% year over year). Net income was $2.08B, a net margin of 10.1%.

Annual revenue · 2025: $20.63B
  1. $17.59B2021
  2. $18.34B2022
  3. $19.55B2023
  4. $19.67B2024
  5. $20.63B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+4.84%
2025 vs 2024
Net income growth
+4.57%
2025 vs 2024
Net margin
10.1%
2024: 10.1%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
Operating cash flow1682901,05059394.0250913-1194191,050650-67.0
Depreciation and amortization160153146148148136140149148144153156
Capital expenditure-100-178-134-110-86.0-152-102-64.0-145-94.0-80.0-70.0
Investing cash flow-115-2,500-269-148-223-407-240-349-188-88.0-120-84.0
Financing cash flow-23621.0-292-1651,361-286-1,276-57.0-153-900-24.0-227
Dividends paid-16.0-16.0-16.0-16.0-16.0-16.0-14.0-14.0-14.0-13.0-14.0-14.0
Share repurchases-202-119-1.0-108-105-28.0-3.0-37.0-11.0-2.0-31.0—
Debt issued0.01,1521,2411.01,4931.01.0-1.02.0-14.020.0—
Debt repaid-9.0-1,004-1,502-4.0-4.0-257-1,256-3.0-153-849—-3.0
Effect of exchange rates2.0-37.0-2.0-16.057.027.0-75.0-22.0-19.024.0-31.0-11.0
Net change in cash-180-2,2274852641,289-416-679-54759.086.0475-389
Free cash flow68.01129164838.098.0811-183274956570-137
Levered free cash flow-1.564.81,012416-83.130.01,061-87.5318934667-251